Literature DB >> 1773329

24-hour survival of autotransfused red cells in elective aortic surgery: a comparison of two intraoperative autotransfusion systems.

P Kent1, S Ashley, P J Thorley, A Shaw, A Parkin, R C Kester.   

Abstract

Twelve patients undergoing elective aortic surgery had intraoperative autotransfusion using either the Haemonetics Cell Saver or the Solcotrans device. The 24-h post-transfusion survival of the patients' preoperative red cells, labelled with indium-111, was compared with the survival of salvaged red cells labelled with chromium-51. A correction coefficient for the instability of the indium-111 label was calculated from the study of red cell survival in six healthy volunteers. There was no significant difference in the volume of circulating red cells measured using each isotope, indicating that extensive early destruction of the autotransfused red cells does not occur. The percentage survival of autotransfused red cells at 24 h was similar to that of the red cells that had not undergone salvage. Both devices were comparable with respect to the effects of cell salvage on the 24-h survival rate of autotransfused red cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773329     DOI: 10.1002/bjs.1800781221

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

Review 1.  [Foreign blood saving measures in orthopedic surgery].

Authors:  P Reize; N Wülker
Journal:  Orthopade       Date:  2007-06       Impact factor: 1.087

2.  Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration.

Authors:  Steven M Frank; Bagrat Abazyan; Masahiro Ono; Charles W Hogue; David B Cohen; Dan E Berkowitz; Paul M Ness; Viachaslau M Barodka
Journal:  Anesth Analg       Date:  2013-02-28       Impact factor: 5.108

3.  Intraoperative autologous blood transfusion for hemoperitoneum resulting from ectopic pregnancy or ovarian bleeding during laparoscopic surgery.

Authors:  Takashi Yamada; Yukiko Okamoto; Hajime Kasamatsu; Hiroshi Mori
Journal:  JSLS       Date:  2003 Apr-Jun       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.